E

Everest Medicines Ltd
HKEX:1952

Watchlist Manager
Everest Medicines Ltd
HKEX:1952
Watchlist
Price: 37.7 HKD -2.71% Market Closed
Market Cap: 12.3B HKD
Have any thoughts about
Everest Medicines Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Everest Medicines Ltd

Wall Street analysts forecast Everest Medicines Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Everest Medicines Ltd is 29.82 HKD with a low forecast of 24.75 HKD and a high forecast of 46.2 HKD.

Lowest
Price Target
24.75 HKD
34% Downside
Average
Price Target
29.82 HKD
21% Downside
Highest
Price Target
46.2 HKD
23% Upside
Everest Medicines Ltd Competitors:
Price Targets
OXB
Oxford BioMedica PLC
25% Upside
AELIS
Aelis Farma SA
229% Upside
SOBI
Swedish Orphan Biovitrum AB (publ)
31% Upside
HOWL
Werewolf Therapeutics Inc
548% Upside
MYGN
Myriad Genetics Inc
61% Upside
RXRX
Recursion Pharmaceuticals Inc
76% Upside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
14% Downside
YMAB
Y-mAbs Therapeutics Inc
106% Upside

Revenue
Forecast

Revenue Estimate
Everest Medicines Ltd

The compound annual growth rate of Everest Medicines Ltd's revenue for the next 3 years is 159%.

N/A
Past Growth
159%
Estimated Growth
Estimates Accuracy
-97%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Everest Medicines Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Net Income
Forecast

Net Income Estimate
Everest Medicines Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Everest Medicines Ltd's stock price target?
Price Target
29.82 HKD

According to Wall Street analysts, the average 1-year price target for Everest Medicines Ltd is 29.82 HKD with a low forecast of 24.75 HKD and a high forecast of 46.2 HKD.

What is Everest Medicines Ltd's Revenue forecast?
Projected CAGR
159%

The compound annual growth rate of Everest Medicines Ltd's revenue for the next 3 years is 159%.

Back to Top